drugset / Trial / NCT02205580

Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children

NCT02205580

Phase 4 Unknown 60 enrolled Jin Ni
RandomizedParallel-groupDouble-blindTreatment

Summary

Postoperative pain following tonsillectomy or adeno-tonsillectomy in children is severe and sometimes last for days. Sufentanil is used by epidural route for postoperative analgesia in children. There are few reports about its use for postoperative analgesia by continuous intravenous infusion. Its complications include , hypoxia, sedation, pruritus ,nausea and/or vomiting. The investigators design this protocol to test efficacy of analgesia of three different rates of continuous intravenous sufentanil infusion for postoperative pain management following coblation tonsillectomy or adeno-tonsillectomy in children. The investigators also compare incidence rate of complications for three groups.

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified 0.02 ug/kg Intravenous
Subject Sufentanil Other / unclassified 0.03 ug/kg Intravenous
Subject Sufentanil Other / unclassified 0.04 ug/kg Intravenous